RENEE HERNANDEZ: Open Payments
NPI 1588189922 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,864 in 95 payments from 15 companies in 2025. Trend: 2023 $2,344 · 2024 $1,318 · 2025 $1,864
Food & beverage: $1,780Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $563 |
| Janssen Biotech, Inc. | 14 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $234 |
| Madrigal Pharmaceuticals | 5 | $150 |
| Regeneron Healthcare Solutions, Inc. | 8 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $106 |
| Abbott Laboratories | 4 | $59 |
| PFIZER INC. | 3 | $58 |
| Ipsen Biopharmaceuticals, Inc | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 4 | $53 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, DUPIXENT, ENTYVIO, LINZESS, XIFAXAN, SKYRIZI.
Industry payments across TX — which companies pay providers there.
